Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.

Study Objective: To evaluate the impact of pharmacologic venous thromboembolism (VTE) prophylaxis on risk of hemorrhage while hospitalized in patients with chronic liver disease (CLD) and concurrent coagulopathy.

Design: Retrospective, multicenter chart review.

Setting: Five hospital, university-affiliated network in eastern Pennsylvania.